Cargando…

Consensus-based recommendations for the management of juvenile localised scleroderma

In 2012, a European initiative called Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and management regimens in Europe for children and young adults with rheumatic diseases. Juvenile localised scleroderma (JLS) is a rare...

Descripción completa

Detalles Bibliográficos
Autores principales: Zulian, Francesco, Culpo, Roberta, Sperotto, Francesca, Anton, Jordi, Avcin, Tadej, Baildam, Eileen M, Boros, Christina, Chaitow, Jeffrey, Constantin, Tamàs, Kasapcopur, Ozgur, Knupp Feitosa de Oliveira, Sheila, Pilkington, Clarissa A, Russo, Ricardo, Toplak, Natasa, van Royen, Annet, Saad Magalhães, Claudia, Vastert, Sebastiaan J, Wulffraat, Nico M, Foeldvari, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691928/
https://www.ncbi.nlm.nih.gov/pubmed/30826775
http://dx.doi.org/10.1136/annrheumdis-2018-214697
_version_ 1783443477230518272
author Zulian, Francesco
Culpo, Roberta
Sperotto, Francesca
Anton, Jordi
Avcin, Tadej
Baildam, Eileen M
Boros, Christina
Chaitow, Jeffrey
Constantin, Tamàs
Kasapcopur, Ozgur
Knupp Feitosa de Oliveira, Sheila
Pilkington, Clarissa A
Russo, Ricardo
Toplak, Natasa
van Royen, Annet
Saad Magalhães, Claudia
Vastert, Sebastiaan J
Wulffraat, Nico M
Foeldvari, Ivan
author_facet Zulian, Francesco
Culpo, Roberta
Sperotto, Francesca
Anton, Jordi
Avcin, Tadej
Baildam, Eileen M
Boros, Christina
Chaitow, Jeffrey
Constantin, Tamàs
Kasapcopur, Ozgur
Knupp Feitosa de Oliveira, Sheila
Pilkington, Clarissa A
Russo, Ricardo
Toplak, Natasa
van Royen, Annet
Saad Magalhães, Claudia
Vastert, Sebastiaan J
Wulffraat, Nico M
Foeldvari, Ivan
author_sort Zulian, Francesco
collection PubMed
description In 2012, a European initiative called Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and management regimens in Europe for children and young adults with rheumatic diseases. Juvenile localised scleroderma (JLS) is a rare disease within the group of paediatric rheumatic diseases (PRD) and can lead to significant morbidity. Evidence-based guidelines are sparse and management is mostly based on physicians’ experience. This study aims to provide recommendations for assessment and treatment of JLS. Recommendations were developed by an evidence-informed consensus process using the European League Against Rheumatism standard operating procedures. A committee was formed, mainly from Europe, and consisted of 15 experienced paediatric rheumatologists and two young fellows. Recommendations derived from a validated systematic literature review were evaluated by an online survey and subsequently discussed at two consensus meetings using a nominal group technique. Recommendations were accepted if ≥80% agreement was reached. In total, 1 overarching principle, 10 recommendations on assessment and 6 recommendations on therapy were accepted with ≥80% agreement among experts. Topics covered include assessment of skin and extracutaneous involvement and suggested treatment pathways. The SHARE initiative aims to identify best practices for treatment of patients suffering from PRDs. Within this remit, recommendations for the assessment and treatment of JLS have been formulated by an evidence-informed consensus process to produce a standard of care for patients with JLS throughout Europe.
format Online
Article
Text
id pubmed-6691928
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-66919282019-08-26 Consensus-based recommendations for the management of juvenile localised scleroderma Zulian, Francesco Culpo, Roberta Sperotto, Francesca Anton, Jordi Avcin, Tadej Baildam, Eileen M Boros, Christina Chaitow, Jeffrey Constantin, Tamàs Kasapcopur, Ozgur Knupp Feitosa de Oliveira, Sheila Pilkington, Clarissa A Russo, Ricardo Toplak, Natasa van Royen, Annet Saad Magalhães, Claudia Vastert, Sebastiaan J Wulffraat, Nico M Foeldvari, Ivan Ann Rheum Dis Recommendation In 2012, a European initiative called Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and management regimens in Europe for children and young adults with rheumatic diseases. Juvenile localised scleroderma (JLS) is a rare disease within the group of paediatric rheumatic diseases (PRD) and can lead to significant morbidity. Evidence-based guidelines are sparse and management is mostly based on physicians’ experience. This study aims to provide recommendations for assessment and treatment of JLS. Recommendations were developed by an evidence-informed consensus process using the European League Against Rheumatism standard operating procedures. A committee was formed, mainly from Europe, and consisted of 15 experienced paediatric rheumatologists and two young fellows. Recommendations derived from a validated systematic literature review were evaluated by an online survey and subsequently discussed at two consensus meetings using a nominal group technique. Recommendations were accepted if ≥80% agreement was reached. In total, 1 overarching principle, 10 recommendations on assessment and 6 recommendations on therapy were accepted with ≥80% agreement among experts. Topics covered include assessment of skin and extracutaneous involvement and suggested treatment pathways. The SHARE initiative aims to identify best practices for treatment of patients suffering from PRDs. Within this remit, recommendations for the assessment and treatment of JLS have been formulated by an evidence-informed consensus process to produce a standard of care for patients with JLS throughout Europe. BMJ Publishing Group 2019-08 2019-03-02 /pmc/articles/PMC6691928/ /pubmed/30826775 http://dx.doi.org/10.1136/annrheumdis-2018-214697 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Recommendation
Zulian, Francesco
Culpo, Roberta
Sperotto, Francesca
Anton, Jordi
Avcin, Tadej
Baildam, Eileen M
Boros, Christina
Chaitow, Jeffrey
Constantin, Tamàs
Kasapcopur, Ozgur
Knupp Feitosa de Oliveira, Sheila
Pilkington, Clarissa A
Russo, Ricardo
Toplak, Natasa
van Royen, Annet
Saad Magalhães, Claudia
Vastert, Sebastiaan J
Wulffraat, Nico M
Foeldvari, Ivan
Consensus-based recommendations for the management of juvenile localised scleroderma
title Consensus-based recommendations for the management of juvenile localised scleroderma
title_full Consensus-based recommendations for the management of juvenile localised scleroderma
title_fullStr Consensus-based recommendations for the management of juvenile localised scleroderma
title_full_unstemmed Consensus-based recommendations for the management of juvenile localised scleroderma
title_short Consensus-based recommendations for the management of juvenile localised scleroderma
title_sort consensus-based recommendations for the management of juvenile localised scleroderma
topic Recommendation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691928/
https://www.ncbi.nlm.nih.gov/pubmed/30826775
http://dx.doi.org/10.1136/annrheumdis-2018-214697
work_keys_str_mv AT zulianfrancesco consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT culporoberta consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT sperottofrancesca consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT antonjordi consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT avcintadej consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT baildameileenm consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT boroschristina consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT chaitowjeffrey consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT constantintamas consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT kasapcopurozgur consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT knuppfeitosadeoliveirasheila consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT pilkingtonclarissaa consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT russoricardo consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT toplaknatasa consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT vanroyenannet consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT saadmagalhaesclaudia consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT vastertsebastiaanj consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT wulffraatnicom consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma
AT foeldvariivan consensusbasedrecommendationsforthemanagementofjuvenilelocalisedscleroderma